National HIV Testing Day has raised awareness and confront stereotypes about HIV. Learn about HIV testing options and ...

Discover what non-reactive HIV test results really mean and why testing timing, window periods, and retesting are crucial for ...

The approval of Yeztugo is a momentous step in improving PrEP options available for people vulnerable to contracting ...

From the first reported case of AIDS to the present, what is the history of HIV-AIDS and are there parallels to the COVID-19 pandemic?

Uganda, once hailed globally for its early and effective response to the HIV/Aids epidemic, is now at a dangerous crossroads.

HIV treatment stops the HIV replication that causes immune damage. But there are places in the body where the virus "hides" ...

Learn what a negative HIV test means, why the window period matters, and when you should consider retesting. Essential health ...

Scientific research has gifted us with a range of evidence-based options to protect ourselves from getting infected with HIV.

The drug, in June, received FDA approval as the first twice-yearly pre-exposure prophylaxis (PrEP) option to reduce the risk ...

Worldwide, at least seven people have been "cured" of HIV—or at least have had long-term sustained remission. This means that ...

As Uganda grapples with a resurgence of new HIV infections, we must confront the uncomfortable truth: complacency is our ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.